What did Boston Scientific Corporation pay for Axonics, Inc.?

$3.40B, equivalent to 68.0× EBITDA / 9.30× revenue. Target revenue was approximately $366.0M. Target EBITDA was approximately $50.0M.

ACQUIRED · 2024

Who Acquired Axonics, Inc.?

Boston Scientific Corporation · $3.40B· 68.0× EBITDA

The acquisition

Axonics, Inc. (United States and Canada) was acquired by Boston Scientific Corporation in 2024 for $3.40B. Axonics, Inc. develops therapies for urinary and bowel dysfunction. The company provides therapies and solutions for these conditions, offering the Axonics System for healthcare professionals and patients. It delivers coding and billing resources and support, along with information and resources through its website. Clients can sign up for updates and receive information about products and services. The company was founded in 2012 and is based in Irvine, California.. The deal was priced at 68.0× EBITDA / 9.30× revenue.

Axonics, Inc. at time of acquisition

Revenue

$366.0M

EBITDA

$50.0M

Deal value

$3.40B

EV / EBITDA

68.0×

Other acquisitions by Boston Scientific Corporation

Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.

Elutia BioEnvelope Business · 2025 · $88.0M
Nalu Medical, Inc. · 2025 · $600.0M
Relievant Medsystems, Inc. · 2023 · $850.0M
Acotec Scientific Holdings Limited · 2022 · $805.0M

Similar medical devices acquisitions

Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
Acera Surgical · acquired by Solventum in 2025 · $725.0M
Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M

Run a valuation for a similar medical devices business

Three fields, instant range, backed by 25,592 real M&A transactions including this one.

Open the medical devices calculator →